GREEN CROSS WellBeing Corporation

234690 · KQ · Healthcare / Biotechnology

8,800.00KRW-350.00 (-3.83%)

Price History

Full chart

Market Stats

Previous Close9,150.00

Open9,200.00

Day Range8,720.00 – 9,200.00

52-Week Range6,680.00 – 15,890.00

Volume262.74K

Market Cap200.39B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield1.25%

Beta0.35

50-Day Avg8,978.20

200-Day Avg9,843.35

About

GC WellBeing Corporation provides personalized nutrition injections in South Korea. The company offers health supplements and food; prescription drugs; and aesthetics, as well as nutritional injections, including vitamins and antioxidants. The company was formerly known as GREEN CROSS WellBeing Corporation and changed its name to GC WellBeing Corporation in April 2026. The company was founded in 2004 and is headquartered in Seoul, South Korea.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOMr. SangHyun Kim
Employees335
HeadquartersPark One Tower, Seoul, South Korea, Korea
Websitehttps://www.greencrosswb.com

Leadership

Mr. SangHyun KimCEO & Director · b. 1965

Financials

Income Statement

Currency: KRW	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	36.65B	45.07B	53.88B	66.94B	75.60B	90.97B	109.73B	120.53B	133.80B	164.68B
Growth (%)	-	+22.98%	+19.55%	+24.23%	+12.95%	+20.32%	+20.62%	+9.85%	+11.01%	+23.08%
Cost of Revenue	15.92B	20.13B	23.59B	30.87B	36.41B	42.02B	49.18B	57.65B	68.89B	91.19B
Gross Profit	20.73B	24.94B	30.29B	36.07B	39.19B	48.95B	60.55B	62.89B	64.91B	73.49B
Gross Margin	56.56%	55.34%	56.21%	53.89%	51.84%	53.81%	55.18%	52.17%	48.51%	44.63%
Operating Expense	16.43B	19.73B	22.50B	28.45B	37.79B	41.18B	52.15B	52.43B	51.95B	56.20B
Operating Income	4.30B	5.22B	7.79B	7.62B	1.40B	7.77B	8.40B	10.46B	12.96B	17.29B
Operating Margin	11.73%	11.57%	14.46%	11.39%	1.86%	8.54%	7.65%	8.67%	9.69%	10.50%
EBITDA	-	-	-	-	-	-	12.24B	15.32B	16.90B	22.12B
EBITDA Margin	-	-	-	-	-	-	11.16%	12.71%	12.63%	13.43%
Net Income	3.37B	4.11B	5.68B	5.70B	1.53B	6.70B	8.00B	6.75B	7.07B	10.01B
Net Income Margin	9.20%	9.11%	10.54%	8.51%	2.02%	7.37%	7.29%	5.60%	5.28%	6.08%
R&D	-	-	-	-	5.11B	4.93B	5.04B	6.00B	5.94B	5.79B
R&D as % of Total Revenue	-	-	-	-	6.76%	5.41%	4.60%	4.98%	4.44%	3.51%
Interest Expense	0	0	0	0	114.46M	133.19M	367.41M	1.66B	1.93B	3.54B
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	0.15%	0.15%	0.33%	1.37%	1.45%	2.15%

Balance Sheet

Currency: KRW	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	28.30B	32.86B	38.97B	106.72B	114.57B	139.01B	150.24B	156.55B	161.53B	222.25B
Total Liabilities	7.36B	8.03B	10.13B	23.55B	31.49B	50.71B	54.08B	56.17B	56.57B	109.55B
Total Equity	20.94B	24.84B	28.84B	83.17B	83.08B	88.30B	96.16B	100.39B	104.95B	112.70B
Cash	32.69M	2.09M	1.79M	12.21B	23.62B	1.52M	159.00K	1.60B	1.67B	2.47B
Total Debt	-	-	-	7.14B	7.61B	-	-	-	-	-
Net Debt	-	-	-	-	-	12.23B	22.35B	28.40B	26.53B	62.13B

Cash Flow

Currency: KRW	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-1.56B	4.11B	5.45B	5.41B	-6.19B	8.68B	1.82B	-1.03B	13.71B	5.73B
Investing Cash Flow	313.41M	-4.13B	-645.81M	-45.46B	19.97B	-42.79B	-9.26B	-1.68B	-8.11B	-
Financing Cash Flow	-329.09M	-289.83M	-1.49B	48.76B	-2.34B	19.26B	1.30B	1.66B	-5.53B	-
Capital Expenditure	2.78B	1.13B	646.18M	1.14B	22.33B	42.87B	7.45B	1.85B	3.66B	6.20B
Free Cash Flow	-	-	-	-3.63B	-28.55B	-34.61B	-6.19B	-2.88B	10.05B	-466.79M
Dividends Paid	329.09M	789.83M	987.28M	987.28M	1.42B	887.61M	1.42B	1.78B	1.78B	2.13B
FCF to OCF	-	-	-	-67.09%	461.03%	-398.58%	-339.15%	279.95%	73.27%	-8.15%
Dividend Paid to FCF	-	-	-	-27.18%	-4.97%	-2.56%	-22.96%	-61.55%	17.67%	-456.19%

Earnings

Report Date	Mar 31, 2020	Jun 30, 2020	Sep 30, 2020	Dec 31, 2020	Mar 31, 2021	Jun 30, 2021	Sep 30, 2021	Dec 31, 2021	Mar 31, 2022	Jun 30, 2022	Sep 30, 2022	Dec 31, 2022	Mar 31, 2023	Jun 30, 2023	Sep 30, 2023	Dec 31, 2023	Mar 31, 2024	Jun 30, 2024	Sep 30, 2024	Dec 31, 2024	Mar 31, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	29.42	85.70	68.43	-93.46	42.04	140.77	166.59	28.17	51.78	129.69	188.72	80.52	72.07	117.50	129.10	61.45	69.74	164.09	131.32	33.18	232.90	19.26	193.63	13.00	-171.66	199.70
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap200.39B

Enterprise Value246.86B

Trailing P/E0.00

Forward P/E0.00

Price / Sales1.04

Price / Book1.41

Revenue (TTM)192.21B

Gross Profit (TTM)78.71B

EBITDA23.60B

Profit Margin2.86%

Operating Margin8.89%

Return on Equity4.94%

Return on Assets4.83%

Shares Outstanding17.96M

Shares Float8.45M

Beta0.35

Dividend Yield1.25%

Dividend Rate140.00

Payout Ratio59.66%

Dividends

20261×

140.00Mar 30, 2026

20241×

120.00Dec 27, 2024

20231×

100.00Dec 27, 2023

20221×

100.00Dec 28, 2022

20211×

80.00Dec 29, 2021

20201×

50.00Dec 29, 2020

20191×

80.00Dec 27, 2019